While MDH2 mutations have not previously been observed in breast cancer cases, decreased expression of MDH2 has been observed in triple-negative breast cancer cases compared to HER2-positive breast cancer cases, supporting a role of MDH2 in breast cancer [37]. Here, ERBB2 is linked to triple-negative breast carcinoma.